DESCOVY® (emtricitabine 200mg/tenofovir alafenamide 25mg) tablets HCP

Descovy® (emtricitabine 200mg/tenofovir alafenamide 25mg) tablets hcp email format

Verified email-pattern data for Descovy® (Emtricitabine 200mg/tenofovir Alafenamide 25mg) Tablets Hcp is currently limited. You can still use the company insights and contact sections below.
Please see full Prescribing Information, including BOXED WARNING, at DescovyPI.com, and at DescovyHCP.com. Please see Indication and Important Safety Information below in the pinned post and at https://www.descovyhcp.com/important-safety-information. This product information is intended for US Healthcare Professionals only. To report SUSPECTED ADVERSE REACTIONS, contact Gilead Sciences, Inc. at 1-800-445-3235 or the FDA at 1-800-FDA-1088 or fda.gov/medwatch. Keith Haring Artwork © Keith Haring Foundation. Licensed by Artestar, New York. DESCOVY, the DESCOVY Logo, Gilead, and the GILEAD Logo are trademarks of Gilead Sciences, Inc. or its related companies. ©2024 Gilead Sciences, Inc. All rights reserved. US-DVYP-0502 04/24
Looking for a particular DESCOVY® (emtricitabine 200mg/tenofovir alafenamide 25mg) tablets HCP employee's phone or email?

Descovy® (Emtricitabine 200mg/tenofovir Alafenamide 25mg) Tablets Hcp Questions

Top DESCOVY® (emtricitabine 200mg/tenofovir alafenamide 25mg) tablets HCP Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant